Health Professional Radio - Podcast

Demian Bellumio, Chief Operating Officer and Co-Founder at Nue Life Health , a next-gen mental wellness company that leverages the power of psychedelic drugs, discusses ketamine treatment and the newly launched Nue Care program. The program is a personalized and accessible 6-month aftercare program that focuses on treating the root causes of mental health conditions. He also expresses his concern...

Kim Moran, Head of U.S. Rare Diseases at UCB, discusses the latest UCB data presented at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) annual meeting that builds the body of evidence around the complexities of Myasthenia Gravis . Patients living with myasthenia gravis continue to experience high disease and treatment burden resulting in significant impact on th...

Returning guest, Dr. Ernest Grant, President of the American Nurses Association, joins us as part of an educational flu campaign called Not Today, Flu , which empowers people to get their flu shot. Dr. Grant discusses how primary care providers can initiate conversations with patients about the importance of getting the flu shot, flu shot differences, recent CDC guidelines, combatting vaccine fati...

Dr. Jan Poolman, Head Bacterial Vaccine Discovery and Early Development at Janssen Infectious Diseases and Vaccines, at the Janssen Pharmaceutical Companies of Johnson & Johnson discusses the risks and burdens associated with sepsis and the evaluation of vaccine candidates to potentially protect against life-threatening bacterial infections. #Sepsis Dr. Jan Poolman is Head Bacterial Vaccine Di...

Dr. Theresa A. Hadlock, MD, Director, Division of Facial Plastic and Reconstructive Surgery, Director, Facial Nerve Center, at Massachusetts Eye and Ear and Professor of Otolaryngology-Head and Neck Surgery, Harvard Medical School discusses her research on Facial Plastic and Reconstructive Surgery-Controversies in Facial Reanimation which was presented at the 2022 American Academy of Otolaryngolog...

Dr. Daniel Faden, MD, Assistant Professor of Otolaryngology-Head and Neck Surgery, Harvard Medical School discusses his research on patient knowledge and opinions of human Papillomavirus vaccination for head and neck cancer prevention which was presented at the 2022 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) annual meeting. #OTOMTG22 Dr. Daniel Faden is a Head a...

Regina Blye, Chief Program and Policy Officer at the Reeve Foundation , which advocates for those living with spinal cord injuries (SCIs) discusses the need for proper access to medical diagnostic equipment (MDE) and how policy can be revised to better support accessible healthcare. Examples of MDE that are currently lacking include a dearth of ramps, accessible elevators and weight scales that ar...

Jay Wish MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for outpatient dialysis at Indiana University Health, discusses the challenges of maintaining healthy phosphorus levels in patients. Hyperphosphatemia, or an electrolyte disorder in which there is an elevated level of phosphate in the blood, can cause serious cardiac conditions. In this e...

Dr. Daniel Croley, DMD, Chief Dental Officer at Delta Dental of California and Affiliates discusses Delta Dental's Senior Oral Health Report: Older Americans’ Oral Care Regrets, Barriers and Impact which revealed that Americans aged 50 and older wish they had gone to the dentist more when younger and other key findings. He also shares tips on how older Americans can get their smile back on track....

Dr. Tomasz George, Ph. D., Chief Scientific Officer at Virax Biolabs , a global biotechnology company that focuses on the detection and diagnosis of viral diseases, discusses the development of a proprietary T cell testing platform – Virax Immune. As the diagnostics space moves towards more T cell-based testing, Virax expects to augment the patient/user experience by launching the Virax Immunity m...

Dr. Wendy Pang, Senior Vice President, Research and Translational Medicine at Jasper Therapeutics , a company transforming the field of hematopoietic stem cell (HSC) therapies discusses how cell and gene therapies are important and potentially curative therapies for people with life-threatening leukemias/lymphomas, other hematologic cancers and inherited genetic diseases. Current conditioning regi...

Dr. ​Gregory ​Randolph​, MD, FACS, FACE, Director, Thyroid and Parathyroid Endocrine Surgical Division at Mass Eye and Ear talks​ about his study on Advanced Thyroid Cancer – State of the Art Management that was presented at the 2022 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) annual meeting. #OTOMTG22 With more than 25 years of experience in otolaryngology, Dr....

Sean Bohen, M.D., Ph. D., is President and CEO of Olema Oncology, a company committed to improving outcomes for women living with cancer. Dr. Bohen discusses Olema's lead investigational asset, OP-1250, now in Phase 2 clinical development for women with recurrent, locally advanced, or metastatic ER+/HER2- breast cancer. The initial data from Olema’s Phase 1 studies provide proof-of-concept support...

Dr. Flavia C. L. Hoyte, Allergist and Immunologist, National Jewish Health in Denver, CO, and Associate Professor, Medicine-Allergy/Clinical Immunology at the University of Colorado Hospital, Aurora, CO discusses the first ever CONNECT1 clinical study to evaluate the ProAir ® Digihaler ® (albuterol sulfate), a smart inhaler system compared to standard of care. It has built-in sensors that automati...

Dr. Lora Shahine, MD, FACOG, a reproductive endocrinologist at Pacific Northwest Fertility and Associate Clinical Professor at the University of Washington discusses how remote work has made navigating the logistics of fertility more convenient for people on their paths to parenthood, but also more isolating. The advantages of improved privacy, reduced work stress, and the ease of scheduled appoin...

For 150 years, dentists have used amalgam fillings to fill and repair cavity-stricken teeth, but a newly released study indicates those fillings – which contain 50% mercury – may slowly be poisoning the people they were designed to help. Dr. Mark Geier and Mr. David Geier, authors of a new study “ Dental Amalgam Fillings and Mercury Vapor Safety Limits in American Adults ” that evaluated mercury v...

Dr. John Laird, an interventional cardiologist and Vice President and Chief Medical Officer of Peripheral Vascular Health at Medtronic discusses peripheral artery disease (PAD), risk factors, signs and symptom management, and treatment options. #PeripheralArteryDisease Dr. John Laird is an internationally renowned interventional cardiologist and vice president and chief medical officer of Peripher...

Dr. Firas Zahr, MD, interventional cardiologist and co-director of the Complex Heart Valve Program at Oregon Health & Science University (OHSU) and Director of Interventional Cardiology at OHSU discusses findings from the Intrepid ™ Early Feasibility Study Intermediate-Term Outcomes which were presented as part of the Mitral Innovation Session, at the 34th Transcatheter Cardiovascular Therapeu...

Dr. David Fairchild, MD, MPH, Chief Medical Officer at CVS MinuteClinic discusses the many ways virtual care has evolved since the pandemic’s virtual care boom, based on new data from CVS Health’s Health Care Insights Study . #VirtualCare Dr. Fairchild joined CVS Health in 2019 as the Chief Medical Officer for MinuteClinic and Senior Vice President and Associate CMO within the CVS Health enterpris...

Dr. Todd Johnson, M.D. is the Chief Growth Officer at M2GEN , an oncology-focused health informatics solutions company with the mission to help patients get access to the best treatments by leveraging clinical and molecular data to accelerate the discovery, development, and delivery of tailored and more personalized therapies. #M2GEN Dr. Todd Johnson is Chief Growth Officer for M2GEN. He previousl...

Joe Gordon, President, Global Consumer, Surgical and Vision Care at Bausch + Lomb , a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world, shares his unique point of view on the industry, Bausch & Lomb's recent IPO, the upcoming innovation pipeline, and what he's excited about in this next chapter of the company. #Ey...

Dr. Rajeev Jain, MD, FACP, FASGE, AGAF, board-certified gastroenterologist at Texas Digestive Disease Consultants discusses the importance of early treatment for GI symptoms to avoid future complications. In light of the Trust Your Gut campaign, Dr. Jain wants to educate the public and encourage fellow doctors on normalizing the conversation with patients regarding uncomfortable GI symptoms. #Trus...

Sloane Allebes Phillips, VP of Clinical Operations at Iterative Scopes, discusses the advancements of AI-precision medicine in the gastroenterology field and the importance of early and accurate preventative care. Iterative Scopes is increasing the accuracy of colonoscopies with its computer-aided detection tool, SKOUT™. SKOUT assists qualified and trained gastroenterologists in identifying potent...

Dr. Sarah Ringold, MD, MS, Director of Clinical Research in Pediatric Immunology at The Janssen Pharmaceutical Companies of Johnson & Johnson discusses the US FDA approval of STELARA ® (ustekinumab) for the treatment of pediatric patients six years of age and older with active psoriatic arthritis (PsA). Healthcare providers now have access to a first-in-class treatment option – with an establi...

Dr. Clayton Lau , chief, Division of Urology and Urologic Oncology at City of Hope , a leading-edge cancer research and treatment organization, discusses how prostate-specific membrane antigen (PSMA) PET scans significantly improve prostate cancer detection and treatment. He talks about single-port robotic prostatectomy that improves recovery time and how prostate surgery is increasingly becoming...